Literature DB >> 3033648

Monoclonal antibodies to the human insulin receptor that activate glucose transport but not insulin receptor kinase activity.

J R Forsayeth, J F Caro, M K Sinha, B A Maddux, I D Goldfine.   

Abstract

Three mouse monoclonal antibodies were produced that reacted with the alpha subunit of the human insulin receptor. All three both immunoprecipitated 125I-labeled insulin receptors from IM-9 lymphocytes and competitively inhibited 125I-labeled insulin binding to its receptor. Unlike insulin, the antibodies failed to stimulate receptor autophosphorylation in both intact IM-9 lymphocytes and purified human placental insulin receptors. Moreover, unlike insulin, the antibodies failed to stimulate receptor-mediated phosphorylation of exogenous substrates. However, like insulin, two of the three antibodies stimulated glucose transport in isolated human adipocytes. One antibody, on a molar basis, was as potent as insulin. These studies indicate, therefore, that monoclonal antibodies to the insulin receptor can mimic a major function of insulin without activating receptor kinase activity. They also raise the possibility that certain actions of insulin such as stimulation of glucose transport may not require the activation of receptor kinase activity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3033648      PMCID: PMC304888          DOI: 10.1073/pnas.84.10.3448

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  13 in total

Review 1.  The insulin receptor and tyrosine protein kinase activity.

Authors:  M H Cobb; O M Rosen
Journal:  Biochim Biophys Acta       Date:  1984

2.  Characterization of the serum from a patient with insulin resistance and hypoglycemia. Evidence for multiple populations of insulin receptor antibodies with different receptor binding and insulin-mimicking activities.

Authors:  R De Pirro; R A Roth; L Rossetti; I D Goldfine
Journal:  Diabetes       Date:  1984-03       Impact factor: 9.461

Review 3.  Cellular oncogenes and retroviruses.

Authors:  J M Bishop
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

4.  The role of antireceptor antibodies in stimulating phosphorylation of the insulin receptor.

Authors:  Y Zick; R W Rees-Jones; S I Taylor; P Gorden; J Roth
Journal:  J Biol Chem       Date:  1984-04-10       Impact factor: 5.157

5.  Preferential degradation of the beta subunit of purified insulin receptor. Effect on insulin binding and protein kinase activities of the receptor.

Authors:  R A Roth; M L Mesirow; D J Cassell
Journal:  J Biol Chem       Date:  1983-12-10       Impact factor: 5.157

Review 6.  The nature and regulation of the insulin receptor: structure and function.

Authors:  M P Czech
Journal:  Annu Rev Physiol       Date:  1985       Impact factor: 19.318

Review 7.  The molecular mechanism of insulin action.

Authors:  C R Kahn
Journal:  Annu Rev Med       Date:  1985       Impact factor: 13.739

8.  Insulin receptor phosphorylation may not be a prerequisite for acute insulin action.

Authors:  I A Simpson; J A Hedo
Journal:  Science       Date:  1984-03-23       Impact factor: 47.728

9.  Monoclonal antibodies to the human insulin receptor block insulin binding and inhibit insulin action.

Authors:  R A Roth; D J Cassell; K Y Wong; B A Maddux; I D Goldfine
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

10.  Hexose transport in human adipocytes: factors influencing the response to insulin and kinetics of methylglucose and glucose transport.

Authors:  O Pedersen; J Gliemann
Journal:  Diabetologia       Date:  1981-06       Impact factor: 10.122

View more
  29 in total

Review 1.  Antibodies directed to the insulin receptor. Clinical aspects and applications to the study of insulin action.

Authors:  R De Pirro; P Borboni; M A Marini; A Montemurro; G Sesti; R Lauro
Journal:  J Endocrinol Invest       Date:  1990-12       Impact factor: 4.256

2.  Evidence that human and porcine insulin differently affect the human insulin receptor: studies with monoclonal anti-insulin receptor antibodies.

Authors:  G Sesti; M A Marini; A Montemurro; P Borboni; G Di Cola; A Bertoli; R De Pirro; R Lauro
Journal:  J Endocrinol Invest       Date:  1991-12       Impact factor: 4.256

3.  Microinjection of a protein-tyrosine-phosphatase inhibits insulin action in Xenopus oocytes.

Authors:  M F Cicirelli; N K Tonks; C D Diltz; J E Weiel; E H Fischer; E G Krebs
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

Review 4.  Role of kinases in insulin stimulation of glucose transport.

Authors:  A Klip; A G Douen
Journal:  J Membr Biol       Date:  1989-10       Impact factor: 1.843

Review 5.  The insulin receptor and the molecular mechanism of insulin action.

Authors:  C R Kahn; M F White
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

6.  Negative and positive site-site interactions, and their modulation by pH, insulin analogs, and monoclonal antibodies, are preserved in the purified insulin receptor.

Authors:  C C Wang; I D Goldfine; Y Fujita-Yamaguchi; H G Gattner; D Brandenburg; P De Meyts
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

Review 7.  The regulation of glucose transport in insulin-sensitive cells.

Authors:  H G Joost; T M Weber
Journal:  Diabetologia       Date:  1989-12       Impact factor: 10.122

Review 8.  The biochemistry of diabetes.

Authors:  R Taylor; L Agius
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

9.  Immunohistochemical localization of glucose transporters and insulin receptors in human fetal membranes at term.

Authors:  H J Wolf; G Desoye
Journal:  Histochemistry       Date:  1993-11

10.  A monoclonal anti-peptide antibody reacting with the insulin receptor beta-subunit. Characterization of the antibody and its epitope and use in immunoaffinity purification of intact receptors.

Authors:  R H Ganderton; K K Stanley; C E Field; M P Coghlan; M A Soos; K Siddle
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.